s-nitrosoglutathione has been researched along with Atherosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Deng, J; Fan, F; Feng, J; Han, L; Huang, S; Huo, Y; Li, J; Liu, B; Lü, S; Ma, X; Miao, Y; Wang, X; Xu, Q; Yang, J; Zhang, Y | 1 |
1 other study(ies) available for s-nitrosoglutathione and Atherosclerosis
| Article | Year |
|---|---|
GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation.
Topics: Adaptive Immunity; Aged; Aldehyde Oxidoreductases; Animals; Apolipoproteins E; Atherosclerosis; Female; Humans; Hyperhomocysteinemia; Interferon-gamma; Macrophages; Male; Mice; Mice, Knockout; Middle Aged; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; S-Nitrosoglutathione; T-Lymphocytes | 2018 |